<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 5 Issue 4</issue_number>
<issue_period>2014 (October - December)</issue_period>
<title>Prediction of HLA-DRB1*15 restricted CD4+ epitopes of Indian HIV-1 Gag protein using Insilco approach </title>
<abstract>Human immunodeficiency virus (HIV) a retrovirus that belongs to the Lentiviridae family, is the causative agent for Acquired Immuno Deficiency Syndrome. Certain "protective" HLA alleles play significant role low viraemia condition like HLA-DRB1*15 allele. An Insilco analysis was adopted to identify Gag epitopes vaccine candidates namely P1-P6 (GLNKIVRMYSPTSIL, LGLNKIVRMYSPTSI, LNKIVRMYSPTSILD, NKIVRMYSPTSILDI, IVRMYSPTSILDIKQ, KIVRMYSPTSILDI) restricted to HLA-DRB1*15 allele would aid significant CD4+ T cell immune response against HIV infection and population coverage among Indian population assessed. Three dimensional structure of epitopes P1-P6 modeled using PEPFOLD, and were tested for their binding affinity towards HLA binding groove using GRAMMX based docking studies resulted with conventional hydrogen bonding,pi-donor,pi-sulfur,carbon hydrogen bonding ,pi-alkyl interaction. Thus the interaction between the screened P1-P6 epitopes exhibiting stability would aid immune response. This computational study of a Gag epitope-based peptide vaccine design for HIV would be helpful in determining novel pep­tide antigen targets in GAG proteins which need to be validated in vitro and in vivo experiments.</abstract>
<authors>JEMMY CHRISTY.H AND ALEX ANAND.D</authors>
<keywords>HIV Vaccine, HLA-DRB1*15, Gag epitope, CD4+ T cell response, HLA-Epitope,Affinity.</keywords>
<pages>1212-1222</pages>
</article>
</Journal>
